Colony Capital, Inc. (CLNY) loses confidence of 98 hedge fund managers

Colony Capital, Inc. (NYSE:CLNY) is on recovery track with 18.75% gain from a 1-year low price of $5.28. The company lost -0.48% to attain the price of $6.27 on 07/12/2018. Throughout the recent session, the prices were hovering between $6.221 and $6.31. These shares are 35.57% off its target price of $8.5 and the current market capitalization stands at $3.04B. The recent change has given its price a 2.29% lead over SMA 50 and -57.46% deficit over its 52-week high. The stock witnessed 2.79% gains, 12.37% gains and -42.74% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CLNY’s volatility during a week at 2.27% and during a month it has been found around 3.32%.

Colony Capital, Inc. (CLNY) Top Holders

Institutional investors currently hold around $2.66 billion or 87.6% in CLNY stock. Look at its top three institutional owners. Vanguard Group Inc owns $510.33 million in Colony Capital, Inc., which represents roughly 16.79% of the company’s market cap and approximately 19.21% of the institutional ownership. Similar statistics are true for the second largest owner, Baupost Group Llc/Ma, which owns 49,687,370 shares of the stock are valued at $313.03 million. The third largest holder is Blackrock Inc., which currently holds $204.36 million worth of this stock and that ownership represents nearly 6.72% of its market capitalization.

Colony Capital, Inc. 13F Filings

At the end of March reporting period, 187 institutional holders increased their position in Colony Capital, Inc. (NYSE:CLNY) by some 63,723,902 shares, 230 decreased positions by 89,651,999 and 46 held positions by 268,302,702. That puts total institutional holdings at 421,678,603 shares, according to SEC filings. The stock grabbed 59 new institutional investments totaling 28,493,782 shares while 98 institutional investors sold out their entire positions totaling 54,933,084 shares.

Colony Capital, Inc. (NYSE:CLNY) Insider Trades

Multiple company employees have indulged in significant insider trading. Colony Capital, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Somers John A. has acquired 2,000 shares of Colony Capital, Inc. (CLNY) in trading session dated Mar. 23, 2018. These shares are worth $11,320 and were traded at $5.66 each. The SEC filing shows that Steffens John performed a purchase of 10,000 shares. The Director added these shares by way of transaction on Mar. 06, 2018. The company’s shares were assimilated at $5.94 per share worth to an investment of some $59,400 on account of Steffens John.

Director, Schoenherr Charles W, purchased 16,000 common shares of Colony Capital, Inc. (CLNY) in the open market. In a transaction dated Mar. 06, 2018, the shares were bought at an average price of $5.88, giving away a sum of $94,080. After this purchase, 46,604 common shares of CLNY are directly owned by the insider, with total stake valued at $292,207.

In the transaction dated Mar. 05, 2018, the great number of shares acquired came courtesy the Director; Metz Justin added a total of 12,000 shares at an average price of $5.72, amounting to approximately $68,640. The insider now directly owns 31,867 shares worth $199,806.

Colony Capital, Inc. (CLNY) Analyst Guide

Not many analysts have released their opinion on Colony Capital, Inc. (NYSE:CLNY), with 2 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.